Novo Nordisk A/S
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All NVO news ›Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Investors often weigh the stability of established giants against the high-octane growth of market leaders. Choosing between Bristol Myers Squibb Co. (NYSE:BMY) and Novo Nordisk A/S (NYSE:NVO) requires balancing valuation against expansion…
Novo Nordisk (NVO) Raised Its Outlook, Then Aimed for Average Growth
Novo Nordisk (NYSE:NVO) did something this year that usually pleases investors: it raised its full-year outlook. The shares fell anyway, with investors fixated on pricing pressure and the quality of the beat. Then, at a strategy day in…
Novo Nordisk stock target cut at Citi on lack of margin growth
Investing.com -- Citi Research cut its price target on Danish drugmaker Novo Nordisk to 296 Danish crowns from 310 because the company's guidance for "broadly stable" margins through 2030 leaves little room for margin growth, Citi analysts…
UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.
A value stock is a stock that is trading cheaply relative to its own history, the market, or other companies in the same industry. Often, a value stock is facing business headwinds of some kind. A value trap is a stock that has value…
Novo Nordisk loses another patent behind Ozempic and Wegovy drugs
The EPO has reversed its preliminary opinion in the case of another Novo Nordisk patent and revoked it. Generic drug manufacturers could enter the market several years earlier, possibly as early as 2031. 9 October 2026 by Christina Schulze…
Novo Nordisk introduces new diabetes treatment option in Thailand
Danish drugmaker Novo Nordisk has introduced a higher-dose version of semaglutide in Thailand, giving adults with type 2 diabetes an additional treatment option. The company announced the introduction in a press release published on 7…
Reviewing Tarsus Pharmaceuticals (NASDAQ:TARS) and Novo Nordisk A/S (NYSE:NVO)
Posted by Michael Walen on Oct 10th, 2026 Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) and Novo Nordisk A/S (NYSE:NVO – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…
Novo Nordisk Foundation Postdoctoral Fellowships at Massachusetts Institute of Technology 2027 (Funded)
Deadline: January 29, 2027 The programme invites early career researchers to apply for a three-year fellowship in collaboration with a research group at MIT. Fellows will conduct a research project at MIT for the first two years, followed…
Mercury vs Novo: Wires, ACH and Cash Deposits
Mercury is the stronger choice for a U.S. business that regularly sends wires. Novo is a good fit when standard ACH and included invoicing cover most transactions. Mercury’s business banking terms list no required monthly fee, free ACH and…
Novo's 'Flashy' Ozempic, Wegovy Price Cuts Unlikely To Impact LLY Stock, Says BofA
Shares of Novo Nordisk (NVO) and Eli Lilly (LLY) fell Tuesday after Novo unveiled plans to slash prices on key obesity and diabetes treatments by as much as 50%. Bank of America (BofA) dismissed the move as just a “flashy headline” that is…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com353
-
tradingview.com280
-
finance.yahoo.com213
-
seekingalpha.com128
-
themarketsdaily.com98
Measured across the 4SanFrancisco news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.